Autonomous driving stocks have great potential. Although their emergence can be primarily seen in Asian markets, I don’t believe it will be long before their reach extends to the rest of the world. Autonomous driving stocks promise safer everyday driving and also have use in specific commercial and industrial applications. Although most autonomous driving stocks
As the world shifts to electric vehicles, demand for EV batteries will skyrocket. All of which should be great news for these top EV battery stocks moving forward. Unfortunately, there’s just one problem. There’s not enough battery supplies. As noted by Business Insider, “Ford (NYSE:F), GM (NYSE:GM), and Porsche (OTCMKTS:DRPRY) pointed to delays, constraints, and expenses related
Li Auto (NASDAQ:LI) stock is on the move, and there is a palpable fear in Detroit right now beyond concerns over the United Auto Workers strike. The Chinese hybrid car maker that announced its September results over the weekend. Li delivered 36,060 cars for the month, 105,108 for the quarter, and 244,225 for the nine
In recent times, the buzzing topic in the realm of auto stocks has been the strike initiated by the United Auto Workers Union. However, peering beyond this immediate hurdle, long-term investors should be more interested in the prospects of autonomous driving and the proliferation of electric vehicles (EVs). These transformative trends, vibrant in potential, should
The aerospace and defense industry is a stock market segment with decent growth over the last year. The iShares U.S. Aerospace and Defense ETF (BATS:ITA), the benchmark ETF for tracking the aerospace and defense industry, has increased by 15% this past 12 months. The increase in returns regarding the defense industry is partly due to
The recent crypto rally has sparked excitement, particularly in speculative assets, amid rumors of a new uptrend. And yet, caution is advised. This rally may not sustain for long due to economic concerns and the underperformance of alternative cryptocurrencies. Consequently, high-risk projects are doubtful to perform strongly in the short term, especially until monetary policy
For investment ideas that can potentially lead to life-changing gains, few sectors are as viable as biotech stocks to make you rich. Fundamentally, the biotechnology sector offers potential therapeutic innovations that could change paradigms for patient care. As a result, the space can provide an enticing home for funds earmarked for speculation. Another factor that
The markets have a reason to cheer in the near-term with the debt ceiling crisis averted. Notably, the last quarter has historically been good for equities. Potential reversal in monetary policy stance in 2024 is another impending catalyst for the market. Given these factors, it’s a good time to accumulate some undervalued dividend stocks. In
Two years ago, the prospects for renewable energy stocks seemed bright. Money was flowing into all sorts of new and disruptive technology companies. And government assistance was on the way to the sector, with the Biden Administration set to deliver large incentives to wind and solar companies via the Inflation Reduction Act. Heading into 2024,
Inherently an uncomfortable topic, the concept of stocks to sell arouses significant emotions. Much like sports fans hearing criticisms about their favorite team, a sense of honor is perceived to be violated. Therefore, few investment writers enjoy talking about this subject. But what if the call is coming from inside the house? What I’m referring
At first glance, the concept of coal stocks to buy doesn’t really make a whole lot of sense. After all, social and political winds incentivize the push toward clean and renewable energy sources. On the flipside, coal harkens to memories of the Industrial Age, which is not congruent with the current Information Age. Still, the U.S.
The fourth and final quarter of 2023 is upon us and the year-end holidays are fast approaching. That could mean a boost in the sales of many businesses, from retailers to airlines and e-commerce companies. In mid-September, accounting firm Deloitte released a report forecasting that holiday retail sales will rise between 3.5% and 4.6% this
September lived up to its billing as the worst month of the year. Pulled lowered by the threat of higher interest rates, a looming government shutdown, and rising energy prices, U.S. indices ended September in the red. However, there’s still reason for optimism for some of the market’s top stocks and indices. For one, the final
If you have your finger on the geopolitical pulse, your next best move could potentially be to target agriculture or Ag stocks. Why? Fundamentally, the underlying ag stocks industry responds to supply and demand. And since humans will always need to eat, reasonably stable agro businesses should enjoy permanent relevance. However, a more pressing catalyst
With an undeniable shift towards electric vehicles (EVs), the demand for lithium has grown immensely. As we look ahead, market analysts suggest that U.S. electric vehicle sales could account for more than 50% of total car sales by 2030. However, while lithium demand surges, investments in its supply infrastructure lag behind. By 2035, we could
In the ever-evolving investment realm, the theme of flying car stocks is catching on. Groundbreaking advancements in the sector are propelling the best flying car stocks. Moreover, these pivotal moments have effectively paved the runway for the commercialization of flying cars, with takeoff expected in the next 18 to 24 months. While we’ve seen impressive
The Sphere is seen during its opening night with the U2:UV Achtung Baby Live concert at the Venetian Resort in Las Vegas on Sept. 29, 2023. Tayfun Coskun | Anadolu Agency | Getty Images Check out the companies making headlines in midday trading. Sphere Entertainment — Shares of the media and entertainment company climbed 10%
A recent article in Barron’s about Chinese households opting to save rather than spend suggested that the country would have difficulty pulling out of the economic tailspin it’s been in since the pandemic began in early 2020. That’s terrible news for Chinese stocks. “An increasingly common belief is that China’s struggling economy, faced with headwinds
Biotech stocks have had a rough post-pandemic. In a year where the S&P500 is up more than 10% year to date, the biotech sector is still negative to flat. Some of this may come from mean reversion, the biotech sector went wild during the pandemic search for COVID cures and vaccines. But it also shows
With a few exceptions, pharmaceutical stocks have underperformed the broader market this year. The S&P Pharmaceutical Index is down 3% year to date versus a 12% gain in the benchmark S&P 500. Several reasons account for the underperformance, ranging from a focus on technology stocks to the patent expirations for several blockbuster drugs. One such